April 8, 2026

Science Chronicle

A Science and Technology Blog

April 8, 2026

Science Chronicle

A Science and Technology Blog

SARS-CoV-2

AntiviralCoronavirusCOVID-19SARS-CoV-2

Restrictive voluntary license of COVID-19 antivirals compromises access, says Leena Menghaney

In an email, Leena Menghaney, South Asia Head of Médecins Sans Frontières’s Access Campaign, says that the voluntary license will

Read More
AntiviralCoronavirusCOVID-19

Pfizer’s antiviral Paxlovid is a major advancement potentially for all coronaviruses, says Gagandeep Kang

In an email, Dr. Gagandeep Kang, Professor of Microbiology at CMC Vellore explains the significance of paxlovid antiviral for treatment,

Read More
CoronavirusImmunisationSARS-CoV-2Vaccines

India falters in administering COVID-19 second dose

No new variant in India According to INSACOG, AY4.2, a Delta variant sublineage, which is slowly increasing in proportion to

Read More
CoronavirusCOVID-19SARS-CoV-2

‘COVID-19 pandemic far from over’ even as global death toll crosses five million

Effects of vaccination The speed at which the virus had killed people slowed down a bit since summer this year

Read More
CoronavirusCOVID-19SARS-CoV-2

Should healthy children be COVID-19 vaccinated on priority?

The National Immunization Technical Advisory Group (NTAGI) Chairperson Dr. N.K. Arora had said children with comorbidities will be prioritised to

Read More
CoronavirusCOVID-19SARS-CoV-2

COVID-19: More studies show hybrid immunity provides better protection

Though 500 health-care workers with or without prior infection were vaccinated, those with hybrid immunity — natural immunity from an infection

Read More
CoronavirusCOVID-19Immunisation

India scripts history with one COVID-19 billion vaccine doses administered

What makes the accomplishment even more outstanding is the fact that the vaccination programme had targeted adults. Unlike the well-established

Read More
CoronavirusCOVID-19SARS-CoV-2

SARS-CoV-2 virus less likely to develop resistance to molnupiravir: Gagandeep Kang

Preliminary data, which is yet to be peer-reviewed, shows molnupiravir can reduce risk of hospitalisation or death by 50% in

Read More
CoronavirusCOVID-19Public HealthVaccines

COVID-19: Soon mRNA vaccines for young children who rarely suffer from severe disease

On September 20, Pfizer released details of the trial that showed the vaccine was safe and generated a “robust” antibody

Read More
CoronavirusCOVID-19Public HealthSARS-CoV-2Vaccines

COVID-19: mRNA vaccine manufacturers loathe to share know-how

In contrast, 54% of the total population in the U.S. is fully vaccinated. After approving booster shots for the immunocompromised

Read More
CoronavirusCOVID-19SARS-CoV-2Vaccines

COVID-19: With nearly 45% vaccinated with one dose, India to finally resume exporting vaccines

The decision comes after the Government severely restricted vaccine exports in March and stopped them in mid-April. The renewed export drive,

Read More
CoronavirusCOVID-19Vaccines

COVID-19: As U.S approves booster shots, under 3.5% vaccinated in Africa

“This doesn’t only hurt the people of Africa, it hurts all of us. The longer vaccine inequity persists, the more

Read More
CoronavirusCOVID-19SARS-CoV-2

COVID-19: Why countries have abandoned the ‘Zero Covid’ strategy

In an email, epidemiologist Dr. Giridhara Babu from Bengaluru’s Public Health Foundation of India explains why the Zero COVID strategy

Read More